Genetics Institute of America
Genetics Institute of America (GIA) is a CAP and CLIA-accredited high complexity molecular diagnostics laboratory specializing in advanced cancer diagnostics and pharma services. The company offers integrated clinical and research services, including prognostic and predictive genetic testing panels such as GIAnomics™ Oncology Germline, Pharmacogenetics, and OncoPredikt HRD™ AI-enabled testing. GIA serves physicians, patients, and pharmaceutical partners to drive precision medicine in cancer and other diseases, emphasizing high-quality, physician- and patient-focused molecular diagnostics that impact patient care. The company is led by experienced MDs and PhDs and maintains accreditations including CAP, CLIA, and GLP, with compliance to 21CFR Part 11. GIA also engages in clinical education, payer and patient education, and community philanthropy, positioning itself as a leader in cancer molecular diagnostics and precision medicine.
Genetics Institute of America
Genetics Institute of America (GIA) is a CAP and CLIA-accredited high complexity molecular diagnostics laboratory specializing in advanced cancer diagnostics and pharma services. The company offers integrated clinical and research services, including prognostic and predictive genetic testing panels such as GIAnomics™ Oncology Germline, Pharmacogenetics, and OncoPredikt HRD™ AI-enabled testing. GIA serves physicians, patients, and pharmaceutical partners to drive precision medicine in cancer and other diseases, emphasizing high-quality, physician- and patient-focused molecular diagnostics that impact patient care. The company is led by experienced MDs and PhDs and maintains accreditations including CAP, CLIA, and GLP, with compliance to 21CFR Part 11. GIA also engages in clinical education, payer and patient education, and community philanthropy, positioning itself as a leader in cancer molecular diagnostics and precision medicine.